Literature DB >> 36208327

Altered prefrontal neurochemistry in the DJ-1 knockout mouse model of Parkinson's disease: complementary semi-quantitative analyses with in vivo magnetic resonance spectroscopy and MALDI-MSI.

Wei Chen1,2, Huihui Liu3, Sijie Liu1,2, Yan Kang1, Zongxiu Nie4,5, Hao Lei6,7.   

Abstract

In vivo proton magnetic resonance spectroscopy (1H-MRS) and matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) are two semi-quantitative analytical methods commonly used in neurochemical research. In this study, the two methods were used complementarily, in parallel, to investigate neurochemical perturbations in the medial prefrontal cortex (mPFC) of 9-month-old DJ-1 knockout mice, a well-established transgenic model for Parkinson's diseases. Convergingly, the results obtained with the two methods demonstrated that, compared with the wild-type (WT) mice, the DJ-1 knockout mice had significantly increased glutathione (GSH) level and GSH/glutamate (Glu) ratio in the mPFC, which likely presented an astrocytic compensatory mechanism in response to elevated regional oxidative stress induced by the loss of DJ-1 function. The results from this study also highlighted (1) the need to be cautious when interpreting the in vivo 1H-MRS results obtained from aged transgenic animals, in which the concentration of internal reference, being whether water or total creatine, could no longer be assumed to be the same as that in the age-matched WT animals, and (2) the necessity and importance of complementary analyses with more than one method under such circumstances.
© 2022. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Glutathione; In vivo 1H-MRS; MALDI-MSI; Parkinson’s disease; Prefrontal cortex

Year:  2022        PMID: 36208327     DOI: 10.1007/s00216-022-04341-8

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.478


  50 in total

Review 1.  The neurochemical profile quantified by in vivo 1H NMR spectroscopy.

Authors:  João M N Duarte; Hongxia Lei; Vladimír Mlynárik; Rolf Gruetter
Journal:  Neuroimage       Date:  2011-12-28       Impact factor: 6.556

Review 2.  Preclinical (1)H-MRS neurochemical profiling in neurological and psychiatric disorders.

Authors:  Moonnoh R Lee; Aleksandar Denic; David J Hinton; Prasanna K Mishra; Doo-Sup Choi; Istvan Pirko; Moses Rodriguez; Slobodan I Macura
Journal:  Bioanalysis       Date:  2012-07       Impact factor: 2.681

3.  Evaluation of markers of oxidative stress, antioxidant function and astrocytic proliferation in the striatum and frontal cortex of Parkinson's disease brains.

Authors:  Rajeswara Babu Mythri; C Venkateshappa; G Harish; Anita Mahadevan; Uday B Muthane; T C Yasha; M M Srinivas Bharath; S K Shankar
Journal:  Neurochem Res       Date:  2011-04-12       Impact factor: 3.996

Review 4.  Quantitative proton magnetic resonance spectroscopy and spectroscopic imaging of the brain: a didactic review.

Authors:  Jeffry R Alger
Journal:  Top Magn Reson Imaging       Date:  2010-04

5.  The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.

Authors:  P Damier; E C Hirsch; Y Agid; A M Graybiel
Journal:  Brain       Date:  1999-08       Impact factor: 13.501

6.  Increase in external glutamate and NMDA receptor activation contribute to H2O2-induced neuronal apoptosis.

Authors:  F Mailly; P Marin; M Israël; J Glowinski; J Prémont
Journal:  J Neurochem       Date:  1999-09       Impact factor: 5.372

Review 7.  Oxidative stress and the pathogenesis of Parkinson's disease.

Authors:  P Jenner; C W Olanow
Journal:  Neurology       Date:  1996-12       Impact factor: 9.910

8.  Disruption of mitochondrial complex I induces progressive parkinsonism.

Authors:  Patricia González-Rodríguez; Enrico Zampese; Kristen A Stout; Jaime N Guzman; Ema Ilijic; Ben Yang; Tatiana Tkatch; Mihaela A Stavarache; David L Wokosin; Lin Gao; Michael G Kaplitt; José López-Barneo; Paul T Schumacker; D James Surmeier
Journal:  Nature       Date:  2021-11-03       Impact factor: 69.504

9.  Targeting the progression of Parkinson's disease.

Authors:  J L George; S Mok; D Moses; S Wilkins; A I Bush; R A Cherny; D I Finkelstein
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

10.  Glutathione and glutamate in schizophrenia: a 7T MRS study.

Authors:  Jyothika Kumar; Elizabeth B Liddle; Carolina C Fernandes; Lena Palaniyappan; Emma L Hall; Siân E Robson; Molly Simmonite; Jan Fiesal; Mohammad Z Katshu; Ayaz Qureshi; Michael Skelton; Nikolaos G Christodoulou; Matthew J Brookes; Peter G Morris; Peter F Liddle
Journal:  Mol Psychiatry       Date:  2018-06-22       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.